Biogen

Biogen is a biotechnology company focused on developing treatments for neurological diseases, including multiple sclerosis and Alzheimer's disease. Founded in 1978, it pioneers advanced therapies that aim to improve the quality of life for patients with complex conditions affecting the brain and spinal cord. Biogen conducts extensive research and development, leveraging innovative science to discover and deliver new medications. The company is also involved in efforts to advance understanding of neurodegenerative disorders, making it a key player in the biopharmaceutical industry dedicated to improving human health.